Have a feature idea you'd love to see implemented?
Let us know!
RXST RxSight Inc
Price (delayed)
$45.05
Market cap
$1.82B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.82
Enterprise value
$1.81B
Highlights
RXST's gross profit has soared by 102% YoY and by 15% from the previous quarter
RXST's equity has surged by 72% year-on-year
RxSight's quick ratio has increased by 49% YoY but it has decreased by 12% from the previous quarter
Key stats
What are the main financial stats of RXST
Market
Valuations
Earnings
Shares outstanding
40.3M
Market cap
$1.82B
Enterprise value
$1.81B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.45
Price to sales (P/S)
13.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.11
Revenue
$128.29M
EBIT
-$30.65M
EBITDA
-$26.47M
Free cash flow
-$27.17M
Per share
Balance sheet
Liquidity
EPS
-$0.82
Free cash flow per share
-$0.68
Book value per share
$6.99
Revenue per share
$3.22
TBVPS
$7.8
Total assets
$310.47M
Total liabilities
$33.21M
Debt
$11.3M
Equity
$277.26M
Working capital
$264.13M
Debt to equity
0.04
Current ratio
12.67
Quick ratio
11.63
Net debt/EBITDA
0.23
Margins
Efficiency
Dividend
EBITDA margin
-20.6%
Gross margin
68.4%
Net margin
-23.9%
Operating margin
-30.5%
Return on assets
-12.5%
Return on equity
-14%
Return on invested capital
-14.6%
Return on capital employed
-10.6%
Return on sales
-23.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RXST stock price
How has the RxSight stock price performed over time
Intraday
0.54%
1 week
2.02%
1 month
-10.83%
1 year
62.64%
YTD
11.73%
QTD
-8.86%
Financial performance
How have RxSight's revenue and profit performed over time
Revenue
$128.29M
Gross profit
$87.81M
Operating income
-$39.08M
Net income
-$30.69M
Gross margin
68.4%
Net margin
-23.9%
RXST's gross profit has soared by 102% YoY and by 15% from the previous quarter
RXST's revenue has surged by 68% year-on-year and by 11% since the previous quarter
RxSight's net margin has soared by 67% YoY and by 25% from the previous quarter
The company's operating margin has surged by 57% YoY and by 17% QoQ
Growth
What is RxSight's growth rate over time
Valuation
What is RxSight stock price valuation
P/E
N/A
P/B
6.45
P/S
13.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.11
The EPS has surged by 52% year-on-year and by 19% since the previous quarter
RXST's equity has surged by 72% year-on-year
RXST's P/B is 28% below its last 4 quarters average of 9.0
RXST's revenue has surged by 68% year-on-year and by 11% since the previous quarter
RXST's P/S is 20% below its last 4 quarters average of 17.5
Efficiency
How efficient is RxSight business performance
RXST's ROE has soared by 65% YoY and by 27% QoQ
The return on sales has surged by 64% year-on-year and by 25% since the previous quarter
The ROA has soared by 59% YoY and by 27% from the previous quarter
RxSight's return on invested capital has increased by 47% YoY and by 28% QoQ
Dividends
What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RXST.
Financial health
How did RxSight financials performed over time
The total assets has surged by 71% year-on-year
The company's total liabilities has surged by 63% YoY and by 10% QoQ
RxSight's debt is 96% less than its equity
RXST's debt to equity has surged by 100% year-on-year
RXST's equity has surged by 72% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.